1. Cai, Kun, Chen, Shiyu, Zhu, Changhao, He, Zhiwei, Sun, Chengyi. 2022. FOXD1 facilitates pancreatic cancer cell proliferation, invasion, and metastasis by regulating GLUT1-mediated aerobic glycolysis. In Cell death & disease, 13, 765. doi:10.1038/s41419-022-05213-w. https://pubmed.ncbi.nlm.nih.gov/36057597/
2. Kumegawa, Kohei, Yang, Liying, Miyata, Kenichi, Maruyama, Reo. 2023. FOXD1 is associated with poor outcome and maintains tumor-promoting enhancer-gene programs in basal-like breast cancer. In Frontiers in oncology, 13, 1156111. doi:10.3389/fonc.2023.1156111. https://pubmed.ncbi.nlm.nih.gov/37234983/
3. Quintero-Ronderos, Paula, Laissue, Paul. 2018. The multisystemic functions of FOXD1 in development and disease. In Journal of molecular medicine (Berlin, Germany), 96, 725-739. doi:10.1007/s00109-018-1665-2. https://pubmed.ncbi.nlm.nih.gov/29959475/
4. Gao, Yuan-Feng, Liu, Jun-Yan, Mao, Xiao-Yuan, Zhou, Hong-Hao, Liu, Zhao-Qian. 2019. LncRNA FOXD1-AS1 acts as a potential oncogenic biomarker in glioma. In CNS neuroscience & therapeutics, 26, 66-75. doi:10.1111/cns.13152. https://pubmed.ncbi.nlm.nih.gov/31102349/
5. Wu, Huizi, Larribère, Lionel, Sun, Qian, Umansky, Viktor, Utikal, Jochen. 2018. Loss of neural crest-associated gene FOXD1 impairs melanoma invasion and migration via RAC1B downregulation. In International journal of cancer, 143, 2962-2972. doi:10.1002/ijc.31799. https://pubmed.ncbi.nlm.nih.gov/30110134/
6. Huang, Yuanshe, Zhang, Lai, Liu, Tianlei, Liang, E. 2023. LMNB1 targets FOXD1 to promote progression of prostate cancer. In Experimental and therapeutic medicine, 26, 513. doi:10.3892/etm.2023.12212. https://pubmed.ncbi.nlm.nih.gov/37840569/
7. Ma, Yuxin, Han, Jingchao, Luo, Xi. 2021. FOXD1-AS1 upregulates FOXD1 to promote oral squamous cell carcinoma progression. In Oral diseases, 29, 604-614. doi:10.1111/odi.14002. https://pubmed.ncbi.nlm.nih.gov/34403535/
智鼠故事 
